To compare the incidence of the development of chronic hypertension in patients with pre-eclampsia versus pre-eclampsia and intrauterine growth restriction. A prospective observational cohort study was performed. The exposed cohort was defined as patients with pre-eclampsia (PE) and intrauterine growth restriction (IUGR). The diagnosis of pre-eclampsia was defined based on the criteria established by the American College of Gynecology and Obstetrics (ACOG), International Society for the Study of Hypertension in Pregnancy (ISSHP) between 2020 and 2022. The patients were followed up during their pregnancy to determine the percentage that developed IUGR based on the Delphi criteria. Patients with underlying chronic arterial hypertension were excluded. Chronic hypertension was determined as patients who persisted with hypertension after week 12 postpartum. A descriptive analysis was carried out based on averages and percentages. 209 patients were included in the study. Their mean age was 34 (+/-) 5 years, body mass index 29.3 (+/-) 4.5, 58% (121/209) were nulliparous, and 5% (11/209) had in vitro fertilisation. In the exposed cohort, 44 pregnant women (PE + IUGR) were included and in the unexposed cohort, 165 pregnant women (PE) were included, with a 4:1 ratio. The mean gestational age at birth was 33 (+/-) 4 weeks and 37.2 (+/-) 3 weeks (p:0.005), the mean birthweight was 2704 (+/-) 508 grams and 1832 (+/-) 590 grams (p:0.171) in (PE + IUGR) and (PE) respectively. Finally, at 12-week follow-up, 8% (13/165) patients had chronic hypertension in the unexposed group and 15% (7/44) in the exposed group (p: 0.244). In our population, pre-eclampsia with intrauterine growth restriction was not associated with the development of chronic hypertension compared to patients who presented pre-eclampsia without intrauterine growth restriction.